0000899243-19-025927.txt : 20191024 0000899243-19-025927.hdr.sgml : 20191024 20191024191249 ACCESSION NUMBER: 0000899243-19-025927 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191023 FILED AS OF DATE: 20191024 DATE AS OF CHANGE: 20191024 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BELOFF GREGG CENTRAL INDEX KEY: 0001171002 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37566 FILM NUMBER: 191167000 MAIL ADDRESS: STREET 1: C/O CERULEAN PHARMA INC. STREET 2: 840 MEMORIAL DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SYNLOGIC, INC. CENTRAL INDEX KEY: 0001527599 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 261824804 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 301 BINNEY STREET STREET 2: SUITE 402 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-401-9975 MAIL ADDRESS: STREET 1: 301 BINNEY STREET STREET 2: SUITE 402 CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Mirna Therapeutics, Inc. DATE OF NAME CHANGE: 20110809 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-10-23 0 0001527599 SYNLOGIC, INC. SYBX 0001171002 BELOFF GREGG C/O SYNLOGIC, INC. 301 BINNEY STREET, SUITE 402 CAMBRIDGE MA 02142 0 1 0 0 See Remarks Stock Option (right to buy) 2.30 2019-10-23 4 A 0 50000 0.00 A 2029-10-23 Common Stock 50000 50000 D The option vest with respect to 25% of the shares on a date that is 6 months from the date of grant, with the remaining shares to vest in equal monthly installments over the following 18 months, subject to the Reporting Person continuing to provide services to the Issuer as Interim Chief Financial Officer through each such vesting date. Interim Chief Financial Officer /s/ Daniel Bagliebter, Attorney-in-fact 2019-10-24